Daniel Pearce - Associate Professor of Internal Medicine
| Background |
|
Education and Training
Graduated, 1975, University of California, Irvine, CA with BS in Biological Sciences/Honors in Research.
Graduated, 1980, College of Osteopathic Medicine and Surgery, Des Moines, IA with D.O.
Rotating Internship: Michigan Osteopathic Medical Center, Detroit, MI. July 1980 to June 1981.
Internal Medicine Residency: Wayne State University, School of Medicine, Department of Internal Medicine, Detroit, MI. July 1981 to June 1984.
AIDS Mini-Residency: University of California, San Diego, CA. October to November 1988.
|
|
|
|
|
|
Positions
Director of Research, Hospitalist, Staff HIV physician. Director, Prevention and Adherence sections. AltaMed, Los Angeles. 2002-2008
HIV Private and Community Medical and Research Practice 1988-2002
Internal Medicine Consultant to various clinics that serve the poor of the Dominican Republic 1986-1987
Physician II, III, and interim Medical Director of Huron Valley Clinical Complex, a 3500 inmate complex of prisons of the Department of Corrections of the State of Michigan. 1984-1986
|
|
Professional
Certification: American Board of Internal Medicine, 9/84, 0989177.
Credentialed: American Academy of HIV Medicine, HIV Specialist, CA1203B089 till 2007
Clinical Assistant Professor of Internal Medicine at Western University, Pomona, CA ~1992 on.
Clinical Instructor in the Department of Family Medicine (NPs), University of San Diego 1992 to 2002.
Member of National Research Committee of the Community Based Clinical Trials Network. Subcommittee on Wasting and Diarrhea 1994.
Recipient: Philosophy in Action Award: Service to the Poor, Catholic Health Care West, San Diego. May 1994.
Associate Medical Director, ImmDef (HIV), for Mercy Home Health Care. 1992-1996.
Board Member, Secretary of Binational Aids Assistance Project (US-Mexico AIDS). 2/00 to 11/02
Planning Committee for annual International Conference on HIV Adherence, since 12/04
|
|
Selected Publications
|
|
--Pearce, D.,et al, Treatment Education and Advocacy s effect on HIV Viral Load and CD4. Oral presentation at Elements of Success (National Adherence Meeting), Dallas, 12/5-8/02.
--M. Saag, P. Cahn, F. Raffi, M. Wolff, D. Pearce, et al. Efficacy and Safety of Emtricitabine vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients, A Randomized Trial. JAMA, July 14, 2004—Vol 292, No. 2
--Pearce,D. Opperman, J. Vaughn, S. Electronic Medical Record and Prescription Transmission Reduces HIV Medication Refill Response Time and Emergency Refills in Latino Community Clinic. Poster 196. 2nd International Conference on HIV Treatment Adherence, 3/06. also JIAPAC 12/07.
|
Selected Research Participation
(interests: HIV, underserved, people of color)
CMD-HIV-002 (CHORUS): The Psychometric Validation of the US English ISSQoL HIV Questionnaire a Sub-Study to the Collaborations in HIV Outcomes Research/U.S. (CHORUS)
SMART Study: A large, international simple trial comparing two strategies for management of anti-retroviral therapy. NIH, CPCRA/INSIGHT.
|
|
|